These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
333 related items for PubMed ID: 20882700
21. Rho kinase inhibitor fasudil regulates microglia polarization and function. Zhang H, Li Y, Yu J, Guo M, Meng J, Liu C, Xie Y, Feng L, Xiao B, Ma C. Neuroimmunomodulation; 2013; 20(6):313-22. PubMed ID: 23941863 [Abstract] [Full Text] [Related]
22. Rho kinase inhibitor fasudil protects against β-amyloid-induced hippocampal neurodegeneration in rats. Song Y, Chen X, Wang LY, Gao W, Zhu MJ. CNS Neurosci Ther; 2013 Aug; 19(8):603-10. PubMed ID: 23638992 [Abstract] [Full Text] [Related]
23. Inhibition of Rho kinase (ROCK) leads to increased cerebral blood flow and stroke protection. Rikitake Y, Kim HH, Huang Z, Seto M, Yano K, Asano T, Moskowitz MA, Liao JK. Stroke; 2005 Oct; 36(10):2251-7. PubMed ID: 16141422 [Abstract] [Full Text] [Related]
24. The therapeutic potential of Rho kinase inhibitor fasudil derivative FaD-1 in experimental autoimmune encephalomyelitis. Zhao YF, Zhang X, Ding ZB, Yang XW, Zhang H, Yu JZ, Li YH, Liu CY, Zhang Q, Zhang HZ, Ma CG, Xiao BG. J Mol Neurosci; 2015 Mar; 55(3):725-32. PubMed ID: 25223373 [Abstract] [Full Text] [Related]
25. Fasudil, an inhibitor of Rho-associated coiled-coil kinase, improves cognitive impairments induced by smoke exposure. Xueyang D, Zhanqiang M, Chunhua M, Kun H. Oncotarget; 2016 Nov 29; 7(48):78764-78772. PubMed ID: 27791202 [Abstract] [Full Text] [Related]
26. Fasudil regulates T cell responses through polarization of BV-2 cells in mice experimental autoimmune encephalomyelitis. Chen C, Li YH, Zhang Q, Yu JZ, Zhao YF, Ma CG, Xiao BG. Acta Pharmacol Sin; 2014 Nov 29; 35(11):1428-38. PubMed ID: 25263338 [Abstract] [Full Text] [Related]
27. Inhibition of AGEs/RAGE/Rho/ROCK pathway suppresses non-specific neuroinflammation by regulating BV2 microglial M1/M2 polarization through the NF-κB pathway. Chen J, Sun Z, Jin M, Tu Y, Wang S, Yang X, Chen Q, Zhang X, Han Y, Pi R. J Neuroimmunol; 2017 Apr 15; 305():108-114. PubMed ID: 28284330 [Abstract] [Full Text] [Related]
28. Targeting the shift from M1 to M2 macrophages in experimental autoimmune encephalomyelitis mice treated with fasudil. Liu C, Li Y, Yu J, Feng L, Hou S, Liu Y, Guo M, Xie Y, Meng J, Zhang H, Xiao B, Ma C. PLoS One; 2013 Apr 15; 8(2):e54841. PubMed ID: 23418431 [Abstract] [Full Text] [Related]
29. ROCK induced inflammation of the microcirculation during endotoxemia mediated by nitric oxide synthase. McGown CC, Brown NJ, Hellewell PG, Brookes ZL. Microvasc Res; 2011 May 15; 81(3):281-8. PubMed ID: 21354186 [Abstract] [Full Text] [Related]
30. The inhibition of Rho kinase blocks cell migration and accumulation possibly by challenging inflammatory cytokines and chemokines on astrocytes. Guo MF, Meng J, Li YH, Yu JZ, Liu CY, Feng L, Yang WF, Li JL, Feng QJ, Xiao BG, Ma CG. J Neurol Sci; 2014 Aug 15; 343(1-2):69-75. PubMed ID: 24952673 [Abstract] [Full Text] [Related]
31. Rho kinase inhibition by fasudil ameliorates diabetes-induced microvascular damage. Arita R, Hata Y, Nakao S, Kita T, Miura M, Kawahara S, Zandi S, Almulki L, Tayyari F, Shimokawa H, Hafezi-Moghadam A, Ishibashi T. Diabetes; 2009 Jan 15; 58(1):215-26. PubMed ID: 18840783 [Abstract] [Full Text] [Related]
33. Rho kinase inhibition by fasudil attenuates cyclosporine-induced kidney injury. Park JW, Park CH, Kim IJ, Bae EH, Ma SK, Lee JU, Kim SW. J Pharmacol Exp Ther; 2011 Jul 25; 338(1):271-9. PubMed ID: 21474569 [Abstract] [Full Text] [Related]
34. Protective Effects of a Rho Kinase Inhibitor on Paraquat-Induced Acute Lung Injuries in Rats. Zhang L, Li Q, Liu Z, Liu W, Zhao M. Inflammation; 2018 Dec 25; 41(6):2171-2183. PubMed ID: 30088170 [Abstract] [Full Text] [Related]
35. The Rho kinase inhibitor fasudil attenuates Aβ1-42-induced apoptosis via the ASK1/JNK signal pathway in primary cultures of hippocampal neurons. Gao Y, Yan Y, Fang Q, Zhang N, Kumar G, Zhang J, Song LJ, Yu J, Zhao L, Zhang HT, Ma CG. Metab Brain Dis; 2019 Dec 25; 34(6):1787-1801. PubMed ID: 31482248 [Abstract] [Full Text] [Related]
36. Fasudil ameliorates the ischemia/reperfusion oxidative injury in rat hearts through suppression of myosin regulatory light chain/NADPH oxidase 2 pathway. Zhang YS, Tang LJ, Tu H, Wang SJ, Liu B, Zhang XJ, Li NS, Luo XJ, Peng J. Eur J Pharmacol; 2018 Mar 05; 822():1-12. PubMed ID: 29337194 [Abstract] [Full Text] [Related]
37. Inhibition of Rho-kinase Attenuates Left Ventricular Remodeling Caused by Chronic Intermittent Hypoxia in Rats via Suppressing Myocardial Inflammation and Apoptosis. Wang ZH, Zhu D, Xie S, Deng Y, Pan Y, Ren J, Liu HG. J Cardiovasc Pharmacol; 2017 Aug 05; 70(2):102-109. PubMed ID: 28437280 [Abstract] [Full Text] [Related]
38. The Rho kinase inhibitor Fasudil up-regulates astrocytic glutamate transport subsequent to actin remodelling in murine cultured astrocytes. Lau CL, O'Shea RD, Broberg BV, Bischof L, Beart PM. Br J Pharmacol; 2011 Jun 05; 163(3):533-45. PubMed ID: 21309758 [Abstract] [Full Text] [Related]
39. Transcriptomic profiling of astrocytes treated with the Rho kinase inhibitor fasudil reveals cytoskeletal and pro-survival responses. Lau CL, Perreau VM, Chen MJ, Cate HS, Merlo D, Cheung NS, O'Shea RD, Beart PM. J Cell Physiol; 2012 Mar 05; 227(3):1199-211. PubMed ID: 21604263 [Abstract] [Full Text] [Related]
40. Inhibition of intracellular Ca2+ release by a Rho-kinase inhibitor for the treatment of ischemic damage in primary cultured rat hippocampal neurons. Huang L, Li Q, Li H, He Z, Cheng Z, Chen J, Guo L. Eur J Pharmacol; 2009 Jan 14; 602(2-3):238-44. PubMed ID: 19070614 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]